| Name | Title | Contact Details |
|---|---|---|
Devin Blank |
Chief Information Security Officer and Global Head of Cyber Security and Compliance | Profile |
Accelerant is a data-driven risk exchange connecting specialty insurance underwriters with risk capital providers. Founded in 2018 by a group of longtime insurance industry executives and technology experts, our vision is to rebuild the way risk is exchanged – so that it works better, for everyone. For the underwriters we call Members, we deliver a full service offering that includes insights and analytics, distribution management, operational resources, and stable underwriting capacity. Our approach frees our Members to focus on profitable underwriting while growing their businesses. Our portfolio presents attractive, validated, and diversified source of specialty insurance premium to our risk capital provider partners.
RKL is a provider of internal audit, risk management and investment advisory services for credit unions, manufacturing and distribution industries.
The National Basketball Association (NBA) is a professional sports league in North America, established in 1946. Headquartered in New York City, the NBA is one of the four major professional sports leagues in the United States and Canada. It is known for its competitive basketball games, iconic players, and extensive global reach. The NBA organizes regular season games, playoffs, and the NBA Finals, attracting millions of viewers worldwide. It also oversees the NBA G League, which serves as a developmental platform for players and staff, and runs Jr. NBA programs to promote basketball among youth. The league is committed to community outreach through NBA Cares, focusing on building facilities and supporting education and health initiatives. With a strong presence in over 200 countries, the NBA utilizes advanced technology and media platforms to engage fans and enhance their experience.
MPI began with a simple premise -- that ordering metal building supplies could be fast, easy and cost-effective. We knew that builders and contractors faced challenges every day, and we didnt need to be one of them. Since 2001, MPI has been driven to manufacture quality metal panels and building supplies, while continuously improving the customer experience along the way. Metal Panels Inc. is a leading manufacturer of quality metal panels for metal roofing, post-frame, metal building and commercial applications. 15 panels profiles available including curved panels, custom trim produced up to 21. In-plant manufacturing with portable roll-formers for on-site production available. Locations in Tulsa, OK and Kansas City, KS, serving northern Texas, Oklahoma, Kansas, Missouri, Arkansas, Southern Nebraska and Iowa. MPI supplies the metal contractor with everything they need from the slab up.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.